Introduction Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease caused by an aberrant immune response in the gut. Irritable bowel syndrome (IBS) is a common disease that may be ...
Introduction Gastro-oesophageal reflux disease (GORD) is characterised by symptoms (most commonly heartburn) caused by exposure of the oesophageal mucosa to gastric contents. Usually, the macroscopic ...
a Digestive Disease Research Center/Neuroenteric Biology Group, Department of Medicine, UCLA and West LA VA Medical Center, Los Angeles, California, USA, b Section of Gastroenterology (111G-1), Tucson ...
Professor G P vanBerge-Henegouwen, Department of Gastroenterology, University Hospital Utrecht, PO Box 85500, Utrecht, The Netherlands. If you wish to reuse any or ...
Dr J A Williams, Department of Physiology, University of Michigan Medical School, 7744 Medical Science Building II, Ann Arbor, MI 48109-0622, USA. jawillms{at}umich.edu Arginine induced acute ...
1 Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia 2 Department of Psychology, Macquarie University, North Ryde, New South Wales, Australia 3 Department of ...
Objective Data from clinical research suggest that certain probiotic bacterial strains have the potential to modulate colonic inflammation. Nonetheless, these data differ between studies due to the ...
Correspondence to Dr Noel F C C de Miranda, Pathology, Leiden University Medical Center, Leiden, The Netherlands; N.F.de_Miranda{at}lumc.nl Objective A comprehensive understanding of anticancer immune ...
Professor M Trevisan, Department of Social and Preventive Medicine, School of Medicine and Biomedical Sciences, 270 Farber Hall, 3435 Main Street, Buffalo, New York 14214–3000, USA. Email: trevisan{at ...
Gastroenterology, University Hospital Zurich and Institute of Biomedical Engineering, University and ETH Zurich, Switzerland Correspondence to: Dr W Schwizer, Gastroenterology, University Hospital of ...
The earth’s climate is changing because of increasing concentrations of greenhouse gases in the atmosphere, which has already warmed by more than 1°C compared with preindustrial times. The aim of ...
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback